
Pulmonary hypertension zzso defined as elevated pulmonary artery pressure, is common in the general population and associated with increased zzso zzso physicians commonly encounter patients with zzso exercise zzso and/or right heart failure who have elevated pulmonary artery zzso pressure zzso on zzso Although pulmonary zzso zzso may often be considered in this setting, these drugs have been predominantly tested in the subset of zzso patients with pulmonary zzso hypertension zzso zzso zzso alone is not sufficient for the diagnosis of zzso and secondary causes of zzso zzso most commonly left heart disease, are far more prevalent than isolated zzso Treatment of this more common group of patients with zzso due to left heart disease is challenging because there are few evidence-based treatment options, and pulmonary zzso therapy may lead to worsening zzso zzso improving symptoms and avoiding adverse outcomes in patients with zzso requires the zzso zzso understanding the optimal use of zzso for the diagnosis of zzso zzso recognizing the utility and proper interpretation of invasive zzso testing prior to starting pulmonary zzso zzso zzso zzso zzso from pulmonary zzso hypertension due to left heart zzso and zzso understanding the appropriate treatment strategies for zzso and zzso right heart zzso 

